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Results: Our results demonstrate an isolate-dependent and
tage-dependent regulation of these genes for a new set of tested
onors, raising the interest in scaling-up the donors and parasite
solates to be tested.
Conclusion: The selected set of putative virulence-associated
enes will be used to classify ﬁeld-collected isolates according to
heir putative virulence.
(This work was supported by NIAID/NIH Grant # 5P50AI074178
nd a joint action Laboratoire International Associé of the Tunisian
inistry for Higher Education, Research and Technology/ French
entre National de Recherche Scientiﬁque).
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he efﬁcacy of artemether-lumefantrine in treating uncompli-
atedmalaria: a study in Samarinda, EastKalimantan, Indonesia
. gunawan1,∗, P. Amaliana2
A. Wahab Sjahranie General Hospital, Samarinda, Indonesia
Mulawarman University School of Medicine, Samarinda, Indonesia
Background: Resistance to antimalarial drugs such as chloro-
uine, sulfadoxin-pyrimethamine has been reported from almost
ll endemic areas in the world, including Indonesia. Some stud-
es in Indonesia showed plasmodium resistance to chloroquine or
ulfadoxin-pyrimethaminewere from20% to as high as 80%. There-
ore, these drugs should be replaced by artemisinin derivatives that
urrently known as the most potent antimalarial. Artemisinin Com-
ination Therapy (ACT) has been used in Indonesia since 2004 and
ow there are three ACTs recommended by The Ministry of Health.
he aim of this study is to evaluate the efﬁcacy of artemether-
umefantrine in treating uncomplicated malaria.
Methods: This study was conducted at A. Wahab Sjahranie
eneral Hospital Samarinda, East Kalimantan, Indonesia from
anuary 2010 to December 2011. Subjects were uncomplicated
dult malaria patients treated with ﬁxed-dose combination of
0mg artemether and 120mg of lumefantrine (Coartem®) 1 tablet
very 12hours for 3 days. The variables measured were fever clear-
nce time (FCT) and parasite clearance time (PCT)
Results: During the period of 24months, therewere 47 patients
ulﬁlled the criteria of this study, consisting of 45 males (95.83%)
nd 2 females (4.17%). Age distribution was as follow: 15-24 years
0 (22.92%), 25-44 years 30 (62.50%), 45-64 years 7 (14.58%). There
ere 26 patients (56.25%) infected by P. falciparum and 21 (43.75%)
y P. vivax. MeanFCT in the group infected by P. falciparum was
6.6hours and in group infected by P. vivax was 7.1 hours. On the
hird day of treatment (D3), all subjects were free of fever. Mean
CT for P. falciparum groupwas 1.92 days and for P. vivax group 1.90
ays. On D3, 92.3% of P. falciparum group were free of parasites and
n the P. vivax group95.2%. OnD4, all patientswere free of parasites.
o patients developed into severe malaria. No signiﬁcant adverse
ffects were found in this study.
Conclusion: Artemether-lumefantrine has high efﬁcacy against
ncomplicated falciparum and vivax malaria. Adequate clinical andfectious Diseases 16S (2012) e158–e316 e161
parasitological response (ACPR) is found 92.3% for P. falciparum and
95.2% for P. vivax.
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Background: The cardiac hydatidosis is a rare and serious
localization which can complicate of an arterial hypertension pul-
monary (PH) consequence of a secondary pulmonary embolism in
the rupture of the hydatid cysts (HC) in the right cardiac cavities or
a ﬁstulization of a hepatic HC in the inferior vena cava (IVC).
Methods: To review 2 cases reports to illustrates a unusual eti-
ology of PH
Results: Case report 1: 37 years old woman is investigated
a lung and renal syndrome mimiking ANCA vasculitis. Medical
history begins a few weeks rather with a acute dyspnoea mim-
icking embolism disease and leading to the diagnosis of a release
of pulmonary ball. The degradation of the renal function requir-
ing 9 sessions of hemodialysis which allows to get back the renal
function. An bilateral pulmonary embolism at the origin of a pul-
monary hypertension (PH) is observed in the following up. The
cardiac MRI make the diagnosis of HC localized in the right ventri-
cle complicatedwith a hydatic pulmonary embolism. Liver scanner
tomography imaging does not localizeHC at the hepatic level nor at
the level of the IVC. The patient receives a symptomatic treatment
and is transferred in thoracic and cardiac surgery.
Case report 2: 27-year-old man in the history of bilateral lung-
wort hydatidos witch was operated three years among devellops
an pulmonary embolism revealed by an acute dyspnoea and a
hemoptysis. The data of the thoracic angioscan conﬁrms an sec-
ondary bilateral massive pulmonary embolism in the rupture of a
cardiac HC of the right ventricle. So the patient beneﬁts a cardiac
surgery (cystectomy) under extracorporeal circulation. The imme-
diate course is favorable. However in 3 months of the intervention
the patient is seen again for a dyspnoea stage III of NYHAwith signs
of right-sided heart failure. The cardiac echo-Doppler ultrasound
method objectiﬁes then PA (80mm Hg of pulmonary arterial sys-
tolic pressure) and note dilatation of the right cavities. The cardiac
MRI does not objectives local recurrence.
Conclusion: PH is dramatic complication of the rupture of the
HC of the right ventricle and aggravates the prognosis of this still
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ndemic multifocal disease proving a systematic cardiac explo-
ation (MRI) associated in abdominal vascular exploration to verify
he vacuity of the IVC in all hydatidosis.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.695
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he effect of combined therapy using arthemisinin and red
ruit oil towards theerythrocyteMmlondyaldehide level inmice
alb/c infected with Plasmodium berghei
. Iskandar
Medical Faculty Brawijaya University, Malang- East Java, Indonesia
Background: Reactive Oxygen Species (ROS) are involved in the
ost antimalarial response and pathological process during malar-
al infection. Besides antimalarial drug therapy, antioxidant like
ed fruit oil is needed as adjuvant therapy to prevent complica-
ion. Experimental studies were carried out to determine the effect
f the combination of artemisinin and red fruit oil to erythrocyte
DA level in BALB/c mice infected with Plasmodium berghei.
Methods: This studywas experimental study using BALB/cmice
hich infectedwith Plasmodium berghei. Therewere 3 groups, con-
rol group, arthemisinin group and combined group
Results: The result of data analysis showed that at the 3rd day,
he erythrocytes MDA level signiﬁcantly decreased (p<0.05) in the
roup of mice with artemisinin therapy (p=0.020) and the group
f mice with combination therapy at the 1st, 2nd, and 3rd doses
with each p is 0.005; 0.005; 0.001) compared with the group of
alarial mice. At the 5th day, the erythrocytes MDA level signif-
cantly decreased in the group of mice with artemisinin therapy
p=0.000) and the group of mice with combination therapy at the
st, 2nd, and 3rd doses (with each p is 0.000) compared with the
roup of malarial mice. At the 5th day, the erythrocytes MDA level
lso signiﬁcantly decreased in the group of mice with combination
herapy at the 1st, 2nd, and 3rd doses (with each p is 0,015; 0,031;
nd 0,016) compared with the group of artemisinin mice
Conclusion: It can be concluded that the combination of
rtemisinin and red fruit oil decreases erythrocytes MDA level in
ice infected with malaria more than only artemisinin therapy.
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Seroepidemiolgy of Toxoplasma gondii in ante-natal women
attending Kenyatta National Hospital, Kenya
P. Kamau ∗, W. Jaoko, C. Gontier
University of Nairobi, Nairobi, Kenya
Background: Toxoplasma gondii is an obligate intracellular pro-
tozoan, with a worldwide distribution. The deﬁnitive host of the
parasite are feline mammals e.g. the domestic cat. Intermedi-
ate hosts include animals and man. Chronically infected pregnant
women who develop defects in cell-mediated immunity risk reac-
tivation of infection. In HIV infected patients risk of reactivation of
T. gondii occurs with CD4 counts of less than 100 cells /L.
Prevalence of serologic evidence of T. gondii infection varies
depending on geographic locale and population groups.
Methods: The objective of the study was to determine the
seroprevalence of T. gondii infections among the pregnant moth-
ers attending Kenyatta National Hospital (KNH). Cross-sectional
descriptive study.
Sample population was randomly selected and sample size was
derived using Epi calculator, Epi version 2.2 with an expected
prevalence of 14%. Blood was collected from the ante-cubital veins
and testing for the T.gondii tested as per the HUMAN ELISA kit.
Results: Participants who were positive only for IgM were con-
sidered to be having acute infection, while those positive for IgG
onlywere considered to be having chronic infection. Those positive
for both IgM and IgG were considered to have false acute infec-
tion. Those negative for both IgM and IgG were considered to be
uninfected. Upto 27% of the pregnant women had acute infection,
22% chronic and 37%were not exposed and 12%were false positive.
Therewas signiﬁcant negative association of IgG andpast abortions
(P =0.037), (OR 0.5(0.2- 1.0)) and IgM with all gestations (P =0.039)
butno signiﬁcant associationof seroprevalenceof anti- T. godii anti-
bodies with socio-demographic parameters (P>0.05). Reactivation
of T. gondii in HIV infected women could not be established due to
small number obtained.
Conclusion: This study revealed a high percentage of preg-
nant women with anti-T. gondii either acute (23%) or chronic (30%)
seropositivity. This compares with other studies done previously.
T. gondii infection in pregnancy may be an important public health
problem in Kenya. The morbidity and mortality attributable to T.
gondii in newborns warrants further studies, over a longer period,
with a view to strengthening preventive measures.
http://dx.doi.org/10.1016/j.ijid.2012.05.697
